Pathomorphologic classification of coronary atherosclerosis;Pathomorphologie der koronaren Atherosklerose

Herz

Volumn 23, Issue 2, 1998, Pages 69-77

  Ihling, Christian ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acute coronary syndroms; Atherosclerosis; Chronic inflammation; Complications; Endothelin 1; Morphology

Indexed keywords

ENDOTHELIN 1;

ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE CLASSIFICATION; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL SOCIETY; MORPHOMETRICS; REVIEW;

EID: 0031959573     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044538     Document Type: Review

References (70)

1. Alexander RW. Inflammation and coronary artery disease (editorial). N Engl J Med 1994;331:468-9.
2. Amento EP, Ehsani N, Palmer H, Libby P. Cylokines positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1223-30.
3. Annex BH, Denning SM, Channon KM, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995;91:619-22.
4. Appleton I, Tomlinson A, Chander CL, Willoughby DA. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. Lab Invest 1992;67:703-10.
5. Arai H, Hori S, Aramon I, Ohkubo H, Nakanishi S. Cloning and expression of cDNA encoding an endothelin receptor. Nature 1990;348:730-2
6. Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: a morphometric study of early atherosclerotic lesions in young people. Hum Pathol 1993;25:154-9.
7. Bdolah A, Wollberg Z, Amba I, Kloog J, Sokolovsky M. Kochva E Disturbances in the cardiovascular system caused by endothelin and sarafotoxin. Biochem Pharmacol 1989;38:3145-6.
8. Boulanger C, Lüscher T. Release of endothelin from the porcine aorta. J Clin Invest 1990;85:587-90.
9. Brown BG, Fry DL. The fate an fibrogenic potential of subintimal implants of crystalline lipid in the canine aorta. Quantitative histological and autoradiographic studies. Circ Res 1978:43: 261-73.
10. Brown KD, Littlewood CJ. Endothelin stimulates DNA synthesis in Swiss 3T3 cells. Synergy with polypeptide growth factors. Biochem J 1989;263:977-80.
11. Brown MR, Vaughan J, Jimenez LL, Vale W, Baird A. Transforming growth factor-b: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology 1991;129:2355-60.
12. Clozel M, Breu V, Burn K. et al. Pathophysiologic role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 1993;365:759-61.
13. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-81.
14. Denaull JB, Claning A, D'Orleans-Juste P, et al. Processing of proendothelin-1 by human furin convertase. FEBS Lett 1995;362: 276-80.
15. Dohi J, Hahn AWA, Boulanger CM, Buhler FR, Lüscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992;19:131-7.
16. Ehrenreich H, Andreson RW, Fox CH. et al. Endothelins. peptides with potent vasoactive poperties, are produced by human macrophages. J Exp Med 1990;172:1741-8.
17. Falk E. Morphological features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol 1989;63:114E-20E.
18. Gabbiani G, Hirschel BJ, Ryan GB, Statkov PR, Majno G. Granulation tissue as a contractile organ. A study of structure and function. J Exp Med 1972;135:719-34
19. Galis Z, Muszynski M, Sukhova G, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion Circ Res 1994,75:181-9.
20. Galis Z, Sukhova G, Kranzhöfer R, Clark S, Libby P. Makrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995;92:402-6.
21. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
22. Hahn AWA, Resink TJ, Kern F, Bühler FR. Effects of endothelin-1 on vascular smooth muscle cell phenotyptc differentiation. J Cardiovasc Pharmacol 1992,20:Suppl 12:533-6.
23. Hansson GK, Holm J, Jonasson L. Detection of activated T-lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135:169-75.
24. Hansson GK, Jonasson L, Holm J, Clowes MK, Clowes A. Gamma interferon regulates vascular smooth muscle cell proliferation and Ia expression in vivo and in vitro. Circ Res 1988;63:712-9.
25. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994.344:852-4.
26. Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991;88:8154-8.
27. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989;78:225-8.
28. Hiroe M, Hirata Y, Marumo F. et al. Immunohistochemical localization of endothelin in human vascular endothelial cells. Peptides 1989;10:1281-2.
29. Hoff HF, Gaubatz JW. Isolation, purification and characterization of lipoproteins containing apo B from the human aorta. Atherosclerosis 1982;42:273-97.
30. Ihling C, Göbel H, Lippoldt A, et al. Endothelin-1-like-immunoreactivity in human atherosclerotic coronary tissue: A detailed analysis of the cellular distribution of endothelin-1. J Pathol 1996;179:303-8.
31. Ihling C, Göbel H, Schaefer HE, Zeiher AM. Endothelin-1 and chronic inflammation in coronary atherosclerosis associated with acute coronary syndromes. Cell Vision 1995;2:283-8.
32. Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family, three structurally and pharmacologically distinct isopeptides predicted by three separate genes Proc Natl Acad Sci USA 1989;86:2863-7.
33. Kanse SM, Takahashi K, Warren JB. et al. Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol 1991;17:Suppl 7.S113-6.
34. Kochva E, Bdolah A, Wollberg Z. Sarafotoxins and endothelins: evolution, structure and function Toxicon 1993;31:541-68.
35. Komuro I, Kurihara I, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells FEBS Lett 1988;238:249-52.
36. Kovaneii PT, KaartinenM, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995;92:1084-8.
37. Lerman A, Edwards BS, Halett JW, Heublein DM, Sandberg SM, Burnett JC Jr Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325: 997-1001.
38. Lerman A, Webster MWI, Chesebro JH, et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 1993;88:2923-8.
39. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 1992;262:C854-61.
40. Martin-Nizard F, Houssaini HS, Lestavel-Delattre S, Duriez P, Fruchard J-C. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett 1991;293:127-30.
41. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991;84:1457-68.
42. Miyauchi T, Tomobe Y, Shiba R. et al. Involvement of endothelin in the regulation of human vascular tonus: potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990;81:1874-1880
43. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
44. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-61.
45. Murch SH, Braegger CP, Sessa WC, Mac Donald TT. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis. Lancet 1992.339:381-5.
46. Ogawa Y, Nakao K, Arai H, Suga S, et al Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun 1991;178:245-8.
47. Ohlstein EH, Storer JA, Debouck C, Feuerstein G. Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells. Circ Res 1991;69:832-41.
48. Raymond TL, Reynolds SA. Lipoproteins of the extracellular space: alterations in low density lipoproteins of interstitial inflammatory fluid. J Lipid Res 1983;24:113-9.
49. Rekther M, Zhang K, Narayanan A, Phan S, Schork M, Gordon D. Type 1 collagen gene expression in human athersclerosis: localization to specific plaque regions. Am J Pathol 1993;143: 1634-48.
50. Richardson P, Davies M, Born G. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989;2:941-4.
51. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
52. Sakurai T, Yanagisawa M, Takuwa J, et al. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor Nature 1990;348:732-5.
53. Sessa WC, Kaw S, Hecker M, Vane JR. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991;174:613-8.
54. Sessa WC, Kaw S, Zembowicz A, Anggard E, Hecker M, Vane JR Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases. J Cardiovasc Pharmacol 1991;17:Suppl 7:34-8.
55. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK. Physiochemical and histological changes in arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest 1984;73:1590-605.
56. Sprigall DR, Howarth PH, Counihan H, Djukanovic R, Holgate ST, Polak JM. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991;337:697-701.
57. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis. American Heart Association. Circulation 1994;89: 2462-78.
58. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch [Pathol Anat] 1992;421:277-90.
59. Tabuchi J, Nakamura M, Rakugi H, Nagano M, Ogihara T. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem Biophys Res Commun 1989;159: 1304-8.
60. van der Wal AC, Becker AE, van der Loos CM, Das PK. The site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
61. Warner SJC, Friedman GB, Libby P. Immune interferon inhibits proliferation and induces 2′-5′-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J Clin Invest 1989;83:1174-82.
62. Warner SJC, Friedman GB, Libby P. Regulation of major histocompatibility gene expression in cultured human vascular smooth muscle cells. Arteriosclerosis 1989;9:279-88.
63. Wenzel RR, Noll G, Lùscher TF. Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. Hypertension 1994;23:581-6.
64. World Health Organization. The classification of atherosclerotic lesions. Report of a study group. WHO Tech Rep Ser 1985;143: 1-20.
65. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
66. Yanagisawa M, Masaki T, Endothelin, a novel endothelium-derived peptide. Biochem Pharmacol 1989;38:1877-83.
67. Yang Z, Richard D, von Segesser L, et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 1990;82:188-95
68. Yoshizumi M, Kurihara H, Morita T, et al. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 1990;166:324-9.
69. Zeiher AM, Goebel H, Schächinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronay atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstabe angina. Circulation 1995;91:941-7.
70. Zeiher AM, Ihling C, Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet 1994;344:1405-6.